Literature DB >> 30992324

BRCA1-No Matter How You Splice It.

Dan Li1, Lisa M Harlan-Williams1,2, Easwari Kumaraswamy1,3, Roy A Jensen4,2,3,5,6.   

Abstract

BRCA1 (breast cancer 1, early onset), a well-known breast cancer susceptibility gene, is a highly alternatively spliced gene. BRCA1 alternative splicing may serve as an alternative regulatory mechanism for the inactivation of the BRCA1 gene in both hereditary and sporadic breast cancers, and other BRCA1-associated cancers. The alternative transcripts of BRCA1 can mimic known functions, possess unique functions compared with the full-length BRCA1 transcript, and in some cases, appear to function in opposition to full-length BRCA1 In this review, we will summarize the functional "naturally occurring" alternative splicing transcripts of BRCA1 and then discuss the latest next-generation sequencing-based detection methods and techniques to detect alternative BRCA1 splicing patterns and their potential use in cancer diagnosis, prognosis, and therapy. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30992324      PMCID: PMC6497576          DOI: 10.1158/0008-5472.CAN-18-3190

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  135 in total

1.  Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.

Authors:  Kathleen Claes; Jo Vandesompele; Bruce Poppe; Karine Dahan; Ilse Coene; Anne De Paepe; Ludwine Messiaen
Journal:  Oncogene       Date:  2002-06-13       Impact factor: 9.867

2.  Distinct transcription start sites generate two forms of BRCA1 mRNA.

Authors:  C F Xu; M A Brown; J A Chambers; B Griffiths; H Nicolai; E Solomon
Journal:  Hum Mol Genet       Date:  1995-12       Impact factor: 6.150

3.  Mutations and polymorphisms in the familial early-onset breast cancer (BRCA1) gene. Breast Cancer Information Core.

Authors:  F J Couch; B L Weber
Journal:  Hum Mutat       Date:  1996       Impact factor: 4.878

4.  Splicing and multifactorial analysis of intronic BRCA1 and BRCA2 sequence variants identifies clinically significant splicing aberrations up to 12 nucleotides from the intron/exon boundary.

Authors:  Phillip J Whiley; Lucia Guidugli; Logan C Walker; Sue Healey; Bryony A Thompson; Sunil R Lakhani; Leonard M Da Silva; Sean V Tavtigian; David E Goldgar; Melissa A Brown; Fergus J Couch; Amanda B Spurdle
Journal:  Hum Mutat       Date:  2011-04-12       Impact factor: 4.878

5.  Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas.

Authors:  C A Wilson; L Ramos; M R Villaseñor; K H Anders; M F Press; K Clarke; B Karlan; J J Chen; R Scully; D Livingston; R H Zuch; M H Kanter; S Cohen; F J Calzone; D J Slamon
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

6.  Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007.

Authors:  Gordon F Schwartz; Kevin S Hughes; Henry T Lynch; Carol J Fabian; Ian S Fentiman; Mark E Robson; Susan M Domchek; Lynn C Hartmann; Roland Holland; David J Winchester; Benjamin O Anderson; Banu K Arun; Harry Bartelink; Philip Bernard; Bernardo Bonanni; Blake Cady; Krishna B Clough; Stephen A Feig; Sylvia H Heywang-Köbrunner; Anthony Howell; Claudine Isaacs; Daniel B Kopans; Robert E Mansel; Shahla Masood; Juan P Palazzo; Peter I Pressman; Lawrence J Solin; Michael Untch
Journal:  Breast J       Date:  2009 Jan-Feb       Impact factor: 2.431

7.  BRCA1 mutations in primary breast and ovarian carcinomas.

Authors:  P A Futreal; Q Liu; D Shattuck-Eidens; C Cochran; K Harshman; S Tavtigian; L M Bennett; A Haugen-Strano; J Swensen; Y Miki
Journal:  Science       Date:  1994-10-07       Impact factor: 47.728

8.  Mutations of the BRCA1 gene in hereditary breast and ovarian cancer in the Czech Republic.

Authors:  P Pohlreich; J Stríbrná; Z Kleibl; M Zikán; R Kalbácová; L Petruzelka; B Konopásek
Journal:  Med Princ Pract       Date:  2003 Jan-Mar       Impact factor: 1.927

9.  miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors.

Authors:  Patryk Moskwa; Francesca M Buffa; Yunfeng Pan; Rohit Panchakshari; Ponnari Gottipati; Ruth J Muschel; John Beech; Ritu Kulshrestha; Kotb Abdelmohsen; David M Weinstock; Myriam Gorospe; Adrian L Harris; Thomas Helleday; Dipanjan Chowdhury
Journal:  Mol Cell       Date:  2010-12-30       Impact factor: 17.970

10.  Novel transcripts from a distinct promoter that encode the full-length AKT1 in human breast cancer cells.

Authors:  Jeffrey W Schmidt; Barbara L Wehde; Kazuhito Sakamoto; Aleata A Triplett; William W West; Kay-Uwe Wagner
Journal:  BMC Cancer       Date:  2014-03-15       Impact factor: 4.430

View more
  7 in total

1.  DoChaP: the domain change presenter.

Authors:  Shani T Gal-Oz; Nimrod Haiat; Dana Eliyahu; Guy Shani; Tal Shay
Journal:  Nucleic Acids Res       Date:  2021-07-02       Impact factor: 16.971

2.  TIPE1 Inhibits Breast Cancer Proliferation by Downregulating ERK Phosphorylation and Predicts a Favorable Prognosis.

Authors:  Wei Hu; Chun-Mei Feng; Ling-Yun Liu; Na Li; Feng Tian; Jian-Xin Du; Yi Zhao; Xin-Xin Xiang; Kui Liu; Pei-Qing Zhao
Journal:  Front Oncol       Date:  2019-05-22       Impact factor: 6.244

3.  The BRCA1 c.4096+3A>G Variant Displays Classical Characteristics of Pathogenic BRCA1 Mutations in Hereditary Breast and Ovarian Cancers, But Still Allows Homozygous Viability.

Authors:  Adalgeir Arason; Bjarni A Agnarsson; Gudrun Johannesdottir; Oskar Th Johannsson; Bylgja Hilmarsdottir; Inga Reynisdottir; Rosa B Barkardottir
Journal:  Genes (Basel)       Date:  2019-11-01       Impact factor: 4.096

Review 4.  BRCA1 and Breast Cancer: Molecular Mechanisms and Therapeutic Strategies.

Authors:  Xiaoyu Fu; Wei Tan; Qibin Song; Huadong Pei; Juanjuan Li
Journal:  Front Cell Dev Biol       Date:  2022-03-01

Review 5.  Splicing alterations in healthy aging and disease.

Authors:  Brittany Lynn Angarola; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2021-02-09       Impact factor: 9.957

6.  Skeletal Muscle Function Is Dependent Upon BRCA1 to Maintain Genomic Stability.

Authors:  Michael D Tarpey; Adam J Amorese; Elizabeth R LaFave; Everett C Minchew; Kelsey H Fisher-Wellman; Joseph M McClung; Eli G Hvastkovs; Espen E Spangenburg
Journal:  Exerc Sport Sci Rev       Date:  2021-10-01       Impact factor: 6.642

Review 7.  Electrochemical Nanobiosensors for Detection of Breast Cancer Biomarkers.

Authors:  Veronika Gajdosova; Lenka Lorencova; Peter Kasak; Jan Tkac
Journal:  Sensors (Basel)       Date:  2020-07-20       Impact factor: 3.576

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.